[go: up one dir, main page]

WO2006053379A1 - Improved nutraceutical composition - Google Patents

Improved nutraceutical composition Download PDF

Info

Publication number
WO2006053379A1
WO2006053379A1 PCT/AU2005/001741 AU2005001741W WO2006053379A1 WO 2006053379 A1 WO2006053379 A1 WO 2006053379A1 AU 2005001741 W AU2005001741 W AU 2005001741W WO 2006053379 A1 WO2006053379 A1 WO 2006053379A1
Authority
WO
WIPO (PCT)
Prior art keywords
phytonutrient
nutritional
composition according
nutraceutical
composition
Prior art date
Application number
PCT/AU2005/001741
Other languages
French (fr)
Inventor
Mark L. Wahlqvist
Naiyana Wattanapenpaiboon
Original Assignee
Universal Food Solutions Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2004906558A external-priority patent/AU2004906558A0/en
Application filed by Universal Food Solutions Pty Ltd filed Critical Universal Food Solutions Pty Ltd
Priority to AU2005306575A priority Critical patent/AU2005306575A1/en
Publication of WO2006053379A1 publication Critical patent/WO2006053379A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/01Hydrocarbons
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L19/00Products from fruits or vegetables; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/01Hydrocarbons
    • A61K31/015Hydrocarbons carbocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07Retinol compounds, e.g. vitamin A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Definitions

  • the present invention relates to a nutraceutical and/or cosmetic composition and/or modified food composition derived from one or more extracts of various plant components.
  • the present invention also relates to a method of prophylactically or therapeutically treating a disease or degenerative effect
  • phytonutrients As well as contributing to the colour, texture, flavour and smell of plants and plant derived foods, phytonutrients have complementary and overlapping biological effects, including antioxidant effects, modulation of detoxification enzymes, stimulation of the immune system, modulation of hormone metabolism and antibacterial and antiviral effects.
  • Phytonutrients can be categorised in accordance with either their plant sources, chemical structure or functions.
  • phytonutrients in food products are classified according to their functions, such as antioxidants or phytoestrogens, which reflect phytonutrient content. This classification is less than satisfactory however as the actual health benefits many phytonutrients provide is, as yet, poorly defined.
  • discussion of phytonutrients is conducted based on a classification by chemical structure, for example carotenoids, flavonoids and glucosinolates. However, such a classification is not admitted to be commonly used or employed, particularly in the food industry.
  • Flavonoids are polyphenols compounds comprising 15 carbon atoms, with two aromatic rings connected by a three carbon bridge. They are found throughout the plant kingdom, present in high concentrations in the epidermis of leaves and the skin of fruit.
  • Flavonoids have been found in fruits and vegetables including apples, pears and onions as well as in tea and wine. In plants, flavonoids, as secondary metabolites, are involved in diverse processes, such as UV protection, pigmentation, stimulation of nitrogen-fixing nodules and disease resistance.
  • Flavonoids consist mainly of flavonols (kaempferol, quercetin, myricetin), flavones (apigenin, luteolin), flavanols (catechins, epicatechins, proanthocyanins), isoflavones (daidzein, genistein), flavanones (naringin, hesperidin), and anthocyanidins.
  • flavonoids By acting as antioxidants, flavonoids reduce oxidative damage to DNA and influence other processes of cell proliferation that are regulated through the oxidation-reduction reactions. In addition, they can modulate the activity of specific phase I and phase Il enzymes and therefore inhibit the metabolic activation of carcinogens.
  • Flavonols in particular epigallocatechin gallate (EGCC), have been identified as the principal antimutagenic and anticarcinogenic compound in green tea. The beneficial effects of drinking tea have been observed in relation to blood pressure, serum cholesterol and other lipids.
  • EGCC epigallocatechin gallate
  • Carotenoids (jS-carotene, lycopene, lutein) are the most well-known of a group known as terpenoids, which are structurally very diverse and are classified according to the number of C5 isoprenoid units incorporated in their structures.
  • the pro-vitamin A activity is probably the first function known for dietary carotenoids, especially ⁇ -carotene, although not all of them possess this activity.
  • Most carotenoids possess antioxidant, immuno-enhancement, antimutagenic, and anticarcinogenic functions. Because of the antioxidant property of carotenoids, the possibility exists that these compounds reduce lipid peroxidation, oxidative stress and free radical damage. Accordingly, they may protect against coronary heart disease, cancer and cataracts.
  • Carotenoids are responsible for many of the red, orange and yellow colours of edible fruits and vegetables, for example, carrots, tomatoes and corn. They are also found in green leafy vegetables such as spinach.
  • Nitrogen and sulphur containing compounds such as the glucosinolates found in the members of the Brassica genus (broccoli, cabbage, mustard), have received much attention recently. They are nitrogen and sulphur containing glycosides which in damaged tissues come into contact with the myrosinase enzyme and are hydrolysed, releasing the aglycone.
  • lsothiocyanates and organosulphides are found in mustard oils and are widely distributed in plants. They have a variety of pharmacological and toxic activities, including goitrogenic, antibacterial, antifungal and antiprotozoal actions. Several substances in this group could block the toxic and neoplastic effects of a wide variety of chemical carcinogens.
  • Plants of the Allium genus are also rich in sulphur containing compounds, such as S-methyl cysteine sulphoxide and S-allyl cysteine sulphoxide.
  • sulphur containing compounds such as S-methyl cysteine sulphoxide and S-allyl cysteine sulphoxide.
  • onions, garlic and compounds derived from them can exhibit health-promoting effects, for example, garlic is known for its health- promoting effects in relation to cardiovascular disease and some forms of cancer.
  • terpenoid group other than carotenoids
  • limonenes which have the fragrance of oranges and lemons
  • glycyrrhizic acid found in liquorice root
  • sterols sitosterol and stigmasterol
  • Coenzyme Q or ubiquinones which are found in all organisms and function as electron carriers for the electron transport chain in mitochondria, are also terpenoids with C40-C50 side chains.
  • flavonoids have been shown in vitro and in vivo to possess antimutagenic and anticarcinogenic properties, dietary flavonoid intake was not an important determinant of cancer mortality. No associations were found between flavonol and flavone intake and total and site-specific cancer mortality in the Zutphen Elderly Study. Similar results were also observed in the Seven countries Study, where the intake of flavanols and flavones ranged from 3 mg/day in a Finnish cohort to 70 mg/day in a Japanese cohort.
  • a nutraceutical composition including one or more extracts of one or more plant components, the one or more extracts providing a combination of phytonutrient materials, the type and amount of which are in excess of a minimum value predetermined to provide a therapeutically or prophylactically desirable effect.
  • administration of the nutraceutical composition according to this aspect of the present invention, orally or topically may function to treat a disease or a degenerative effect.
  • administration of the nutraceutical composition according to this aspect of the present invention, orally or topically may improve skin health, reduce signs of skin ageing and/or reduce other forms of skin deterioration.
  • long-term supplementation for 12 weeks with 24 mg/d of a carotenoid mix supplying similar amounts of beta-carotene, lutein and lycopene ameliorates redness of human skin induced by UV light.
  • nutraceutical composition may optionally include a nutraceutically acceptable carrier.
  • nutraceutical refers to any food or food ingredient (or additive) considered to provide medical or health benefits, including the prevention or treatment of disease.
  • Food and food substances may qualify for health claims only if they meet FDA requirements, which require that the claims be supported by sufficient scientific evidence. However, nutraceuticals are not regulated as strictly as drugs.
  • extract refers to any subset of a plant or plant product and may include, but is not limited to juice, pulp, infusion, cutting, distillate, distillation residue, pressing, nectar, pomace (crushing residue), etc.
  • plant component may include, but is not limited to, any one or more of the following: leaf, stem, root, fruit, seed, nut, tuber, bulb, flower or branch, and the like, whether used in a fresh form or a dried form.
  • a plant may be selected from the group consisting of, but not limited to one or more of olive trees, palm trees, fruit trees, plants used to make tea, other plants from which fruit and vegetables are derived, etc.
  • the "minimum value” is indicated by way of a numeric “score” which gives an indication of the phytonutrient nutritional quality of the nutraceutical composition (or other composition depending on the aspect of the invention).
  • the minimum value is predetermined based on, for example, the Reference Intakes (Rl) of the various phytonutrients present in the composition.
  • Rl is a nutrient-based reference value for use in, inter alia, planning and assessing diets.
  • the nutrient-based values are based on the lowest continuing intake level of a nutrient that, for a specified indicator of adequacy, will maintain a defined level of nutriture in an individual.
  • the Rl is the amount of a phytonutrient per 100 kcal that a person should consume to ensure adequate intake of the phytonutrient for health purposes.
  • a score may be calculated using any suitable scoring system.
  • the following is a description of one suitable scoring system. However, modifications to this system may be implemented to improve the described system or simply generate a new system.
  • the scoring system being described has five components of varying significance which are based on the content, variety and intactness of the phytonutrients in a nutraceutical composition.
  • the described scoring system has an overall range of 0 to 100.
  • Components 1 to 3 of the described scoring system are each scored in the range of 0 to 25 and the score given is based on the amount of the three major groups of phytonutrients present in a composition - (1) flavonoids, (2) carotenoids and (3) miscellaneous (other phytonutrients, including nitrogen or sulphur containing compounds).
  • the phytonutrients have been classified on the basis of their structures.
  • Table 2 lists the phytonutrient groups (numbered in accordance with their component number) and the sub-groups and individual compounds making up the sub-groups, as well as the major sources of these phytonutrients.
  • Component 4 is scored in the range of 0 to 15 and is based on the amount of variety of phytonutrients in a nutraceutical composition.
  • Component 5 is scored in the range of 0 to 10 and is a measure of the degree to which fresh plant components are altered, either physically, chemically or both from their natural state for incorporation into the extract and/or the nutraceutical composition.
  • the described scoring system is summarised in Table 3.
  • the score for components 1 to 3 is determined by the phytonutrient content of the composition expressed as the phytonutrient density (amount of phytonutrient in ⁇ g (or mg) per 1000 kJ energy (or per 100 kcal) derived from that particular composition).
  • Each phytonutrient group is scored by comparing the phytonutrient density of the composition to the Reference Intakes (Rl) for that phytonutrient.
  • a score is assigned by first calculating the phytonutrient density percentage of the Rl for each phytonutrient in the group. Second, a score from 0 to 25 is proportionately assigned based upon the percentage of the Rl of phytonutrients in each group, with 25 being the highest score for each phytonutrient group when one serving size of the nutraceutical composition provides 100% of the Rl of the phytonutrients of that group.
  • the Rl of a phytonutrient may be based on reports from various cohort studies, where a large number of participants are followed up for long periods of time in order to observe disease incidence.
  • Evidence may be gathered from research in which the associations of phytonutrient intake or consumption of phytonutrient rich foods and disease outcome are examined.
  • the disease outcome may include risk of all-cause mortality, risk of cancer, heart disease and other diseases, and association with risk factors for disease.
  • the Rl may also be determined from daily phytonutrient intakes of populations or sub- populations with longevity or with reduced risk of chronic diseases.
  • Zutphen Elderly Study Korean eIi et al., Arch Intern Med 1996; 156: 637-42; Hertog et al., Lancet 1997; 349: 699
  • the daily reference intake for the flavonol sub-group would be set as 20 mg/day.
  • the Rl for the flavonol sub-group would be 1 mg/100 kcal based on a 2000 kcal per day diet.
  • the Rl may be assigned to the phytonutrient group.
  • the Rl for the phytonutrient group may be derived from the Rl for the major sub-group of the phytonutrient group or from the total Rl for all sub-groups.
  • the scoring system counts the number of phytonutrient sub-groups that contribute substantially to meeting the three phytonutrient group requirements. A substantial contribution could be, for example, when the percentage of Rl for each phytonutrient of the sub-group is summed, a total percentage of greater than 5% for the phytonutrient sub-group.
  • Phytonutrient groups and subgroups are outlined in Table 1. Phytonutrients (and their derivatives) that fall in the same sub-group are counted only once. For each of the phytonutrient groups, a threshold number is set and a maximum score is given even though the number of different phytonutrients exceeds the threshold number. In the described scoring system the threshold numbers for flavonoids is 7, for carotenoids is 3 and for the miscellaneous group, the threshold number is 5. Therefore, the variety score has a range from 0 to 15.
  • Component 5 (the assessment of the intactness of phytonutrients) of the scoring system counts the number of food processing procedures that a nutraceutical composition undergoes (Table 4). The more food processing the composition undergoes, the more the integrity of the phytonutrients is diminished. Thus, the higher number of food processes undergone by the food item, the lower the score will be for component 5.
  • the therapeutically or prophylactically desirable effect may relate to any disease or condition known to the person skilled in the art.
  • diseases or conditions may include, but are not limited to, skin ageing, skin health, skin deterioration, skin conditions, cancer, cardiovascular disease, Alzheimer's disease, bone and joint diseases including osteoporosis and arthritis, obstructive airways diseases including asthma, allergic conditions, conditions affecting the gastrointestinal tract, autoimmune diseases, and diabetes.
  • scoring system described above may also be applied to plant or plant components and even to animal-derived food products that may contain phytonutrients acquired when plant food is consumed by the animal.
  • the nutraceutical composition includes an effective amount of phytonutrient materials selected from the group consisting of flavonols, flavones, flavanols, anthocyanidins, flavanones, chalcones, dichalcones, isoflavones, provitamin A hydrocarbon carotenoids, non-provitamin A carotenoids, hydroxycarotenoids, glucosinolates, allium organosulphur compounds, phytosterols, monoterpenes, hydroxycinnamates, phenolic acids, stilbenes, choline derivatives, or a combination thereof.
  • phytonutrient materials selected from the group consisting of flavonols, flavones, flavanols, anthocyanidins, flavanones, chalcones, dichalcones, isoflavones, provitamin A hydrocarbon carotenoids, non-provitamin A carotenoids, hydroxycarotenoids, glucosin
  • a nutraceutical composition of an embodiment of the present invention may include a combination of phytonutrient materials such that the minimum value is about 25.
  • the value may be about 40, more preferably about 60.
  • the nutraceutical composition according to this aspect of the present invention may further include one or more secondary nutraceutical components active nutritionally and/or therapeutically.
  • the secondary nutraceutical component may be selected from one or more of vitamins, minerals, saccharides and/or other carbohydrates, fats, other nutritional supplements, hormones, and pharmaceuticals.
  • the secondary nutraceutical component when present, may comprise from approximately 0.05% to 50% by weight, preferably approximately 1% to 40% by weight, more preferably 5% to 25% by weight, based on the total weight of the pharmaceutical composition.
  • the nutraceutical composition according to this aspect of the present invention may further include a pharmaceutically acceptable carrier or excipient.
  • the nutraceutical composition may be formulated for administration utilising a suitable route.
  • the nutraceutical composition may be formulated for oral, topical, intravenous, intramuscular, intrarectal, transdermal, sublingual, subcutaneous or intranasal administration. An oral or topical route is preferred.
  • the nutraceutical composition may be formulated as a food ingredient, food additive, tablet, capsule including soft gelatine capsules, caplet, lozenge, liquid including syrup, oil and suspension, powder, granules, chewing gum or the like.
  • the nutraceutical composition may be formulated as a liquid, oil, paste, solution, dispersion, emulsion, lotion, gel, varnish or cream.
  • the nutraceutical composition according to this aspect of the present invention may include a source of monounsaturated fatty acids or a derivative thereof.
  • the source of the monounsaturated fatty acid is an edible oil. More preferably the edible oil is olive oil or red palm oil, or an extract thereof, or a mixture thereof.
  • the source of monounsaturated fatty acids is present in an amount of from approximately 1 mg to 25 g, preferably 50 mg to 10 g, more preferably 100 mg to 5 g.
  • the amount of monounsaturated fatty acids present in the nutraceutical composition amounts to a preferred daily intake of the monounsaturated fatty acids.
  • the nutraceutical composition includes an extract from one or more of leafy green vegetables, garlic, onion, leeks, apple, pear, dried fruits or other food sources of the required phytonutrients, or a mixture thereof, with a source of monounsaturated fatty acids.
  • the source of the monounsaturated fatty acid is an edible oil.
  • the edible oil is olive oil or red palm oil, an extract thereof, or a mixture thereof.
  • nutraceutical composition may optionally include a nutraceutically acceptable carrier.
  • the extracts of the plant components are present in an amount of approximately 1 % to 99% by weight, preferably approximately 5% to 75% by weight, preferably approximately 10 to 50% by weight, based on the total weight of the composition.
  • a cosmetic composition including one or more extracts of one or more plant components, the extracts providing a combination of phytonutrient materials, the type and amount of which are in excess of a minimum value predetermined to provide a therapeutically or prophylactically desirable effect.
  • the cosmetic composition includes an effective amount of phytonutrient materials selected from the group consisting of flavonols, flavones, flavanols, anthocyanidins, flavanones, chalcones, dichalcones, isoflavones, provitamin A hydrocarbon carotenoids, non-provitamin A carotenoids, hydroxycarotenoids, glucosinolates, allium organosulphur compounds, phytosterols, monoterpenes, hydroxycinnamates, phenolic acids, stilbenes, choline derivatives, or a combination thereof.
  • phytonutrient materials selected from the group consisting of flavonols, flavones, flavanols, anthocyanidins, flavanones, chalcones, dichalcones, isoflavones, provitamin A hydrocarbon carotenoids, non-provitamin A carotenoids, hydroxycarotenoids, glucosinolates
  • the minimum value will generally be determined depending on the type of nutraceutical composition being considered.
  • the cosmetic composition according to a preferred aspect of the present invention may include a combination of phytonutrient materials such that the minimum value is about 25.
  • the value may be about 40, more preferably about 60.
  • the cosmetic composition according to this aspect of the present invention may include a source of monounsaturated fatty acids or a derivative thereof.
  • the source of the monounsaturated fatty acid is an edible oil.
  • the edible oil is olive oil or red palm oil, or an extract thereof, or a mixture thereof.
  • the source of monounsaturated fatty acids is present in an amount of from approximately 1 mg to 25 g, preferably 50 mg to 10 g, more preferably 100 mg to 5 g.
  • the amount of monounsaturated fatty acids present in the cosmetic composition amounts to a preferred daily intake of the monounsaturated fatty acids.
  • a cosmetic composition including an extract from one or more of leafy green vegetables, garlic, onion, leeks, apple, pear, dried fruits or other food sources of the required phytonutrients, or a mixture thereof, with a source of monounsaturated fatty acids.
  • the source of the monounsaturated fatty acid is an edible oil.
  • the edible oil is olive oil or red palm oil, an extract thereof, or a mixture thereof.
  • the cosmetic composition of this aspect of the invention may further include a pharmaceutically acceptable carrier or excipient.
  • the extracts of the plant components are present in an amount of approximately 1 to 99% by weight, preferably approximately 5% to 75% by weight, preferably approximately 10 to 50% by weight, based on the total weight of the composition.
  • the cosmetic composition may be formulated for administration utilising a suitable route.
  • the cosmetic composition may be formulated for oral, topical, intravenous, intramuscular, intrarectal, transdermal, subcutaneous, sublingual or intranasal administration.
  • An oral or topical route is preferred.
  • the nutraceutical composition may be formulated as a food ingredient, food additive, tablet, capsule including soft gelatine capsules, caplet, lozenge, liquid including syrup and oil, suspension, powder, granules, chewing gum or the like.
  • the nutraceutical composition may be formulated as a liquid, oil, paste, solution, dispersion, emulsion, lotion, gel, varnish or cream.
  • the cosmetic composition may also further include one or more cosmetic additives.
  • the cosmetic additives may be selected from the group consisting of water-soluble or liposoluble dyes, fillers, lipophilic or hydrophilic active agents, fragrances, additional carriers or excipients, lubricants, buffers, antibacterials, bulking agents, plasticisers, binding agents, antioxidants and stabilising agents.
  • Suitable fillers or excipients may be selected from the group consisting of talc, titanium dioxide, starch, cornstarch, modified cornstarch, kaolin, cellulose (microcrystalline or powdered) and mixtures thereof.
  • Suitable binding agents include polyvinyl pyrrolidine, hydroxypropyl cellulose and hydroxypropyl methyl cellulose.
  • Suitable solution vehicles include, but are not limited to, ethanol, water, propylene glycol, butylene glycol, acetone, or pharmaceutically acceptable vehicles.
  • the cosmetic composition may further include an active agent selected from the group consisting of hydrating agents, UV screening agents, depigmenting agents, bleaching agents and tensioning agents.
  • Suitable lotion bases include, but are not limited to, hydrophilic ointment or petrolatum.
  • Suitable gelling agents include, but are not limited to, xanthan gum, gellan gum, carboxymethylcellulose, polyquaternium-10, methyl cellulose, ethyl cellulose, hydroxyethylcellulose, hydroxypropylcellulose, chitosan, hydroxypropylmethylcellulose, agar-agar, carrageenans, alginates, carob gum, guar gum, gum Arabic, karaya gum, gum tragacanth, ghatti gum, pectins, gelatin, caseinates, hydroxypropyl guar, ammoniated glycyrrhizinate and carbomer.
  • a modified food composition including a nutraceutical composition, as discussed above.
  • the modified food composition may be characterised by exhibiting a numerical value of phytonutrient quality above a predetermined reference value.
  • the predetermined reference value may equate to a maximum numerical value for an unmodified food composition.
  • the modified food composition may include any of the following:
  • dairy products including milk, ice-cream, yoghurt, cheese etc
  • grain based products including rice based products such as rice cakes, corn based products such as pop corn etc
  • products derived at least in part from fruit including tarts, pies, muesli bars, juices, cordials, tinned fruit, snack foods
  • the food composition includes an effective amount of phytonutrient materials selected from the group consisting of flavonols, flavones, flavanols, anthocyanidins, flavanones, chalcones, dichalcones, isoflavones, provitamin A hydrocarbon carotenoids, non-provitamin A carotenoids, hydroxycarotenoids, glucosinolates, allium organosulphur compounds, phytosterols, monoterpenes, hydroxycinnamates, phenolic acids, stilbenes, choline derivatives, or a combination thereof.
  • phytonutrient materials selected from the group consisting of flavonols, flavones, flavanols, anthocyanidins, flavanones, chalcones, dichalcones, isoflavones, provitamin A hydrocarbon carotenoids, non-provitamin A carotenoids, hydroxycarotenoids, glucosinolates
  • the minimum value will generally be determined depending on the type of nutraceutical composition being considered.
  • the food composition according to a preferred aspect of the present invention may include a combination of phytonutrient materials such that the minimum value is about 25.
  • the value may be about 40, more preferably about 60.
  • the food composition according to this aspect of the present invention may further include one or more secondary nutraceutical components active nutritionally and/or therapeutically.
  • the secondary nutraceutical component may be selected from one or more of vitamins, minerals, saccharides and/or other carbohydrates, fats, other nutritional supplements, hormones, and pharmaceuticals.
  • the secondary nutraceutical component when present, may comprise from approximately 0.05% to 50% by weight, preferably approximately 1% to 40% by weight, more preferably 5% to 25% by weight, based on the total weight of the pharmaceutical composition.
  • composition according to this aspect of the present invention may include a source of monounsaturated fatty acids or a derivative thereof.
  • the source of monounsaturated fatty acids is present in an amount of from approximately 1 mg to 25 g, preferably 50 mg to 10 g, more preferably 100 mg to 5 g.
  • the amount of monounsaturated fatty acids present in the food composition amounts to a preferred daily intake of the monounsaturated fatty acids.
  • the source of monounsaturated fatty acid is an edible oil. More preferably, the edible oil is olive oil, red palm oil or an extract thereof, or a mixture thereof.
  • the composition includes an extract from one or more of leafy green vegetables, garlic, onion, leeks, apple, pear, dried fruits or other food sources of the required phytonutrients, or a mixture thereof, with a source of monounsaturated fatty acids.
  • the extracts of the plant components are present in an amount of approximately 1 to 99% by weight, preferably approximately 5% to 75% by weight, more preferably approximately 10 to 50% by weight, based on the total weight of the composition.
  • the composition is used to prophylactically or therapeutically treat skin ageing, skin health, skin deterioration, skin conditions, cancer, cardiovascular disease, Alzheimer's disease, bone and joint diseases including osteoporosis and arthritis, obstructive airways diseases including asthma, allergic conditions, conditions affecting the gastrointestinal tract, autoimmune diseases, and diabetes.
  • the composition is selected from the group consisting of a nutraceutical composition and a cosmetic composition as described above.
  • a method of prophylactically or therapeutically treating a disease or degenerative effect which method includes administering to a human a composition including one or more extracts of one or more plant components, the extracts providing a combination of phytonutrient materials, the type and amount of which are in excess of a minimum value predetermined to provide a therapeutically or prophylactically desirable effect.
  • a method of determining the nutritional value of a nutraceutical composition and applying a phytonutrient nutritional score thereto which method includes:
  • the present invention provides a method of determining the nutritional value of a food composition and applying a phytonutrient nutritional score thereto. Accordingly, the method includes:
  • the food composition may be of any suitable type as described above.
  • the food substance may include a dietary supplement.
  • the food substance is preferably a flour- based substance, a substance containing and/or consisting of fruit and/or vegetables, a rice-based substance or a dairy-based substance.
  • the phytonutrient content, phytonutrient variety and phytonutrient integrity may be determined as described above.
  • the predetermined value ranges are the Reference Intakes described above. More preferably, the predetermined value ranges are determined at regular intervals based on the information available regarding optimal phytonutrient intake at the time.
  • the phytonutrient nutritional score may be determined as described above.
  • phytonutrient nutritional scores are given in the range of 0 to 100.
  • the predetermined value ranges may be compiled in order to create an index of the predetermined value ranges.
  • the phytonutrient nutritional scores which have been determined may be independently compiled in order to create an index of the phytonutrient nutritional scores.
  • the invention provides a method of controlling the nutritional value of a nutraceutical composition and/or a cosmetic composition and/or a food composition consumed by an individual. Accordingly, the method includes:
  • the method is used to increase the phytonutrient nutritional score of the food substance.
  • the invention provides a computer useable medium for determining the nutritional value of nutraceutical composition and/or a cosmetic composition and/or a food composition. Accordingly, such medium includes:
  • (c) means for summing the correlated nutritional components to derive a phytonutrient nutritional score indicative of the nutritional value of the food substance
  • the computer useable medium may be stored in any suitable manner known per se in the prior art.
  • the medium may be selected from a compact disk, digital video disk, hard drive or floppy disk.
  • the computer useable medium is arranged to provide, as an output, a phytonutrient nutritional score and/or a list of any phytonutrient nutritional scores determined by the method described above so as to form an index of phytonutrient nutritional scores.
  • Reference Intakes were calculated based on the data published in the cited references. Generally, data from reports of daily intakes of sub-groups of phytonutrients in populations or sub-populations with longevity or reduced risk of chronic disease were compared and a representative daily intake was calculated for each sub-group of phytonutrients. The Reference Intake, measured in mg/100kcal was calculated from the representative daily intake based on a 2000 kcal per day diet. Table 5 - Reference Intakes
  • the component 1 to 3 scores were proportionately assigned based on the percentage Rl of the sub-group having the highest percentage Rl.
  • the score for the carotenoid group was calculated based on the percentage Rl of the hydroxy carotene sub-group alone, 19 being 77% of the possible total of 25.
  • the variety score (component 4) was determined by summing the number of phytonutrient sub-groups having a value of greater than 5% of the Rl for that phytonutrient sub-group.
  • the integrity score (component 5) is the maximum score available.
  • the percentage Rl of the flavanols, 4% indicated that the flavanols did not contribute substantially to meeting the flavonoid group (component 1) requirement. Accordingly, the flavanol sub-group was not counted in the determination of the variety score.
  • the integrity score assigned to the salad vegetables was the maximum score available as the salad vegetables had not undergone any processing steps which diminished the phytonutrient integrity of the salad vegetables.
  • the integrity score assigned to the ready-to-eat soup was the maximum score available as no processing steps which diminished the phytonutrient integrity of the vegetables had been undergone by the food.
  • flavoured (dairy and soy) drink having the following approximate proportions of ingredients:
  • Table 12 Phytonutrient analysis of 100g of flavoured (dairy and soy) drink
  • the integrity score assigned to the milk drink was the minimum score available due to the high number of processing steps the product was subjected to which diminished the phytonutrient integrity of the drink.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Toxicology (AREA)
  • Polymers & Plastics (AREA)
  • Neurology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Obesity (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)

Abstract

A nutraceutical composition including one or more extracts of one or more plant components, the one or more extracts providing a combination of phytonutrient materials, the type and amount of which are in excess of a minimum value predetermined to provide a therapeutically or prophylactically desirable effect.

Description

IMPROVED NUTRACEUTICAL COMPOSITION
Field of the invention
The present invention relates to a nutraceutical and/or cosmetic composition and/or modified food composition derived from one or more extracts of various plant components. The present invention also relates to a method of prophylactically or therapeutically treating a disease or degenerative effect
Background of the invention
Increasingly, there has been an interest in the role of specific foods composed of compounds that have the potential to favourably affect human biology. Plants and plant derived foods are of particular interest, the beneficial compounds contained in them known as phytonutrients.
As well as contributing to the colour, texture, flavour and smell of plants and plant derived foods, phytonutrients have complementary and overlapping biological effects, including antioxidant effects, modulation of detoxification enzymes, stimulation of the immune system, modulation of hormone metabolism and antibacterial and antiviral effects.
The growing array of phytonutrients opens up opportunities for healthier food choices and for the development of functional foods to serve particular physiological or pathological needs. Health benefits are increasingly used as a selling point for new food products. Many plant foods are used as food ingredients because of their content of phytonutrients, apart from the conventional nutrients. However, there are numerous problems in considering the place of phytonutrients in human health, including that they are numerous, are consumed in conjunction with a few essential nutrients, and their net interactive effect ultimately requires an understanding of food itself and food intake patterns.
Phytonutrients can be categorised in accordance with either their plant sources, chemical structure or functions. Presently, phytonutrients in food products are classified according to their functions, such as antioxidants or phytoestrogens, which reflect phytonutrient content. This classification is less than satisfactory however as the actual health benefits many phytonutrients provide is, as yet, poorly defined. For convenience, discussion of phytonutrients is conducted based on a classification by chemical structure, for example carotenoids, flavonoids and glucosinolates. However, such a classification is not admitted to be commonly used or employed, particularly in the food industry.
Flavonoids are polyphenols compounds comprising 15 carbon atoms, with two aromatic rings connected by a three carbon bridge. They are found throughout the plant kingdom, present in high concentrations in the epidermis of leaves and the skin of fruit.
Flavonoids have been found in fruits and vegetables including apples, pears and onions as well as in tea and wine. In plants, flavonoids, as secondary metabolites, are involved in diverse processes, such as UV protection, pigmentation, stimulation of nitrogen-fixing nodules and disease resistance.
Flavonoids consist mainly of flavonols (kaempferol, quercetin, myricetin), flavones (apigenin, luteolin), flavanols (catechins, epicatechins, proanthocyanins), isoflavones (daidzein, genistein), flavanones (naringin, hesperidin), and anthocyanidins. However, the term 'flavonoid' is sometimes used in the literature to describe only flavonols. By acting as antioxidants, flavonoids reduce oxidative damage to DNA and influence other processes of cell proliferation that are regulated through the oxidation-reduction reactions. In addition, they can modulate the activity of specific phase I and phase Il enzymes and therefore inhibit the metabolic activation of carcinogens.
Flavonols, in particular epigallocatechin gallate (EGCC), have been identified as the principal antimutagenic and anticarcinogenic compound in green tea. The beneficial effects of drinking tea have been observed in relation to blood pressure, serum cholesterol and other lipids.
Carotenoids (jS-carotene, lycopene, lutein) are the most well-known of a group known as terpenoids, which are structurally very diverse and are classified according to the number of C5 isoprenoid units incorporated in their structures. The pro-vitamin A activity is probably the first function known for dietary carotenoids, especially β-carotene, although not all of them possess this activity. Most carotenoids possess antioxidant, immuno-enhancement, antimutagenic, and anticarcinogenic functions. Because of the antioxidant property of carotenoids, the possibility exists that these compounds reduce lipid peroxidation, oxidative stress and free radical damage. Accordingly, they may protect against coronary heart disease, cancer and cataracts. Carotenoids are responsible for many of the red, orange and yellow colours of edible fruits and vegetables, for example, carrots, tomatoes and corn. They are also found in green leafy vegetables such as spinach.
Nitrogen and sulphur containing compounds, such as the glucosinolates found in the members of the Brassica genus (broccoli, cabbage, mustard), have received much attention recently. They are nitrogen and sulphur containing glycosides which in damaged tissues come into contact with the myrosinase enzyme and are hydrolysed, releasing the aglycone.
lsothiocyanates and organosulphides are found in mustard oils and are widely distributed in plants. They have a variety of pharmacological and toxic activities, including goitrogenic, antibacterial, antifungal and antiprotozoal actions. Several substances in this group could block the toxic and neoplastic effects of a wide variety of chemical carcinogens.
Plants of the Allium genus (garlic, onions, leeks, chives) are also rich in sulphur containing compounds, such as S-methyl cysteine sulphoxide and S-allyl cysteine sulphoxide. There is some evidence that onions, garlic and compounds derived from them can exhibit health-promoting effects, for example, garlic is known for its health- promoting effects in relation to cardiovascular disease and some forms of cancer.
Compounds in the terpenoid group (other than carotenoids) that have been reported in the literature include limonenes, which have the fragrance of oranges and lemons, glycyrrhizic acid found in liquorice root, and sterols (sitosterol and stigmasterol) commercially produced from soy beans. Coenzyme Q or ubiquinones, which are found in all organisms and function as electron carriers for the electron transport chain in mitochondria, are also terpenoids with C40-C50 side chains.
The health-promoting effects of certain phytonutrients can be exemplified in relation to skin ageing. It has recently been found that certain foods are associated with less skin wrinkling (Purba et al., J. Am. Coll. Nutr., 2001 , 20, 71-80). Previously, it was widely assumed that genetic predisposition, age, actinic damage and cigarette smoking accounted for most of the skin ageing suffered by much of the population. Purba et al. found foods such as apple, pear, tea, onion, leek, dried fruits and green leafy vegetables were associated with less skin wrinkling. Table 1 shows the amount (in g/day) of the foods and the associated phytonutrients required to effect a one unit reduction in skin damage.
Table 1
The amount of foods and the associated phytonutrients required to effect a one unit reduction in skin damage
Figure imgf000005_0001
Further evidence for food antioxidants being protective against skin damage and cancer risk comes from animal studies with tea catechins (flavonoids) and palm fruit water- extract (polyphenols). However, little is known of the mechanism(s) or key elements in such products. Food-derived flavonoids such as quercetin, kaempferol and myricetin have been shown to have antimutagenic and anticarcinogenic effects in vitro and in vivo. The first population study that drew attention to the health benefits of dietary flavonoids is the Zutphen Elderly Study (Hertog et al. Lancet 1993; 142: 1007-11 ; KeIi et al, Arch Intern Med 1996; 156: 637-42), which was an extension of the Dutch contribution to the Seven Countries Study (Hertog et al. Arch Intern Med 1995;155;381-6). The measurements of five major food flavonoids (the flavanols quercetin, kaempferol and myricetin, and the flavones apigen and luteolin) in 28 vegetables, 9 fruits, and beverages mostly commonly consumed in the Netherlands enabled the estimation of flavonoid intake of the study population. These data have been used in a number of prospective cohort studies and cross-cultural studies on the relation between flavonoid intake and cancer and cardiovascular disease.
Even though flavonoids have been shown in vitro and in vivo to possess antimutagenic and anticarcinogenic properties, dietary flavonoid intake was not an important determinant of cancer mortality. No associations were found between flavonol and flavone intake and total and site-specific cancer mortality in the Zutphen Elderly Study. Similar results were also observed in the Seven Countries Study, where the intake of flavanols and flavones ranged from 3 mg/day in a Finnish cohort to 70 mg/day in a Japanese cohort.
In the Netherlands Cohort study of 120,850 men and women aged 55-69 years, the intake of flavonols and flavones was not associated with the risk of cancer of the colon or the stomach or the lung during 4.3 years of follow-up. However, in a prospective cohort study of about 10,000 men and women aged 15-99 years in Finland, a reduction in risk of lung cancer of about 50% was found in the highest quartile of flavonol intake after 24 years of follow-up. No reduction in risk of cancer at other sites was found.
It is difficult, however, to determine the required intakes of the various phytonutrients found in plants and plant derived foods that will lead to improved health outcomes.
It would be a significant advance in the art if determinants favourable to the prophylactic or therapeutic treatment of a disease or degenerative effect could be located. Accordingly, it is an object of the present invention to overcome, or at least alleviate, one or more of the problems or deficiencies in the prior art.
Summary of the invention
In a first aspect of the present invention there is provided a nutraceutical composition including one or more extracts of one or more plant components, the one or more extracts providing a combination of phytonutrient materials, the type and amount of which are in excess of a minimum value predetermined to provide a therapeutically or prophylactically desirable effect.
Inventors have surprisingly found that administration of the nutraceutical composition according to this aspect of the present invention, orally or topically, may function to treat a disease or a degenerative effect. For example, it has been found that administration of the nutraceutical composition according to this aspect of the present invention, orally or topically, may improve skin health, reduce signs of skin ageing and/or reduce other forms of skin deterioration. For example, long-term supplementation for 12 weeks with 24 mg/d of a carotenoid mix supplying similar amounts of beta-carotene, lutein and lycopene ameliorates redness of human skin induced by UV light.
In addition, the nutraceutical composition may optionally include a nutraceutically acceptable carrier.
The term "nutraceutical" (or nutraceutical), as used herein, refers to any food or food ingredient (or additive) considered to provide medical or health benefits, including the prevention or treatment of disease. Food and food substances may qualify for health claims only if they meet FDA requirements, which require that the claims be supported by sufficient scientific evidence. However, nutraceuticals are not regulated as strictly as drugs.
The term "extract" as used herein refers to any subset of a plant or plant product and may include, but is not limited to juice, pulp, infusion, cutting, distillate, distillation residue, pressing, nectar, pomace (crushing residue), etc. The term "plant component" may include, but is not limited to, any one or more of the following: leaf, stem, root, fruit, seed, nut, tuber, bulb, flower or branch, and the like, whether used in a fresh form or a dried form.
A plant may be selected from the group consisting of, but not limited to one or more of olive trees, palm trees, fruit trees, plants used to make tea, other plants from which fruit and vegetables are derived, etc.
The "minimum value" is indicated by way of a numeric "score" which gives an indication of the phytonutrient nutritional quality of the nutraceutical composition (or other composition depending on the aspect of the invention).
The minimum value is predetermined based on, for example, the Reference Intakes (Rl) of the various phytonutrients present in the composition. The Rl is a nutrient-based reference value for use in, inter alia, planning and assessing diets. The nutrient-based values are based on the lowest continuing intake level of a nutrient that, for a specified indicator of adequacy, will maintain a defined level of nutriture in an individual. The Rl is the amount of a phytonutrient per 100 kcal that a person should consume to ensure adequate intake of the phytonutrient for health purposes.
A score may be calculated using any suitable scoring system. The following is a description of one suitable scoring system. However, modifications to this system may be implemented to improve the described system or simply generate a new system.
The scoring system being described has five components of varying significance which are based on the content, variety and intactness of the phytonutrients in a nutraceutical composition. The described scoring system has an overall range of 0 to 100. Components 1 to 3 of the described scoring system are each scored in the range of 0 to 25 and the score given is based on the amount of the three major groups of phytonutrients present in a composition - (1) flavonoids, (2) carotenoids and (3) miscellaneous (other phytonutrients, including nitrogen or sulphur containing compounds). For the purposes of this scoring system the phytonutrients have been classified on the basis of their structures. Table 2 lists the phytonutrient groups (numbered in accordance with their component number) and the sub-groups and individual compounds making up the sub-groups, as well as the major sources of these phytonutrients.
Table 2
Component 1 - Phytonutrient groups and sub-groups
Figure imgf000009_0001
Figure imgf000010_0001
Component 4 is scored in the range of 0 to 15 and is based on the amount of variety of phytonutrients in a nutraceutical composition. Component 5 is scored in the range of 0 to 10 and is a measure of the degree to which fresh plant components are altered, either physically, chemically or both from their natural state for incorporation into the extract and/or the nutraceutical composition. The described scoring system is summarised in Table 3.
Table 3
Components of a phytonutrient scoring system'
Figure imgf000011_0001
a Component scores between the maximum and minimum cut-off points are assigned proportionately.
The score for components 1 to 3 (hereafter simply referred to as the phytonutrient groups) for any given nutraceutical composition is determined by the phytonutrient content of the composition expressed as the phytonutrient density (amount of phytonutrient in μg (or mg) per 1000 kJ energy (or per 100 kcal) derived from that particular composition).
Each phytonutrient group is scored by comparing the phytonutrient density of the composition to the Reference Intakes (Rl) for that phytonutrient. A score is assigned by first calculating the phytonutrient density percentage of the Rl for each phytonutrient in the group. Second, a score from 0 to 25 is proportionately assigned based upon the percentage of the Rl of phytonutrients in each group, with 25 being the highest score for each phytonutrient group when one serving size of the nutraceutical composition provides 100% of the Rl of the phytonutrients of that group.
Determining adequate intakes of specific food intakes and related phytonutrients is not straightforward. The Rl of a phytonutrient may be based on reports from various cohort studies, where a large number of participants are followed up for long periods of time in order to observe disease incidence. Evidence may be gathered from research in which the associations of phytonutrient intake or consumption of phytonutrient rich foods and disease outcome are examined. The disease outcome may include risk of all-cause mortality, risk of cancer, heart disease and other diseases, and association with risk factors for disease.
The Rl may also be determined from daily phytonutrient intakes of populations or sub- populations with longevity or with reduced risk of chronic diseases. For example, the Zutphen Elderly Study (KeIi et al., Arch Intern Med 1996; 156: 637-42; Hertog et al., Lancet 1997; 349: 699) shows that middle-aged men with flavonoid (flavonol + flavone) intake > 18.3 mg/d had a 50% reduction in the risk of stroke, and those with flavonol intake > 19.1 mg/d had a 42% reduction in the risk of coronary heart disease mortality. In this case, the daily reference intake for the flavonol sub-group would be set as 20 mg/day. In this example, the Rl for the flavonol sub-group would be 1 mg/100 kcal based on a 2000 kcal per day diet.
In an alternate scoring system, the Rl may be assigned to the phytonutrient group. In such a system, the Rl for the phytonutrient group may be derived from the Rl for the major sub-group of the phytonutrient group or from the total Rl for all sub-groups.
In relation to component 4 (assessment of phytonutrient variety), the scoring system counts the number of phytonutrient sub-groups that contribute substantially to meeting the three phytonutrient group requirements. A substantial contribution could be, for example, when the percentage of Rl for each phytonutrient of the sub-group is summed, a total percentage of greater than 5% for the phytonutrient sub-group. Phytonutrient groups and subgroups are outlined in Table 1. Phytonutrients (and their derivatives) that fall in the same sub-group are counted only once. For each of the phytonutrient groups, a threshold number is set and a maximum score is given even though the number of different phytonutrients exceeds the threshold number. In the described scoring system the threshold numbers for flavonoids is 7, for carotenoids is 3 and for the miscellaneous group, the threshold number is 5. Therefore, the variety score has a range from 0 to 15.
Component 5 (the assessment of the intactness of phytonutrients) of the scoring system counts the number of food processing procedures that a nutraceutical composition undergoes (Table 4). The more food processing the composition undergoes, the more the integrity of the phytonutrients is diminished. Thus, the higher number of food processes undergone by the food item, the lower the score will be for component 5.
Table 4
Processes during food manufacturing which could diminish the integrity of phytonutrients
Figure imgf000013_0001
The therapeutically or prophylactically desirable effect may relate to any disease or condition known to the person skilled in the art. For example, such diseases or conditions may include, but are not limited to, skin ageing, skin health, skin deterioration, skin conditions, cancer, cardiovascular disease, Alzheimer's disease, bone and joint diseases including osteoporosis and arthritis, obstructive airways diseases including asthma, allergic conditions, conditions affecting the gastrointestinal tract, autoimmune diseases, and diabetes.
A person skilled in the art would understand that the scoring system described above may also be applied to plant or plant components and even to animal-derived food products that may contain phytonutrients acquired when plant food is consumed by the animal.
Preferably, the nutraceutical composition includes an effective amount of phytonutrient materials selected from the group consisting of flavonols, flavones, flavanols, anthocyanidins, flavanones, chalcones, dichalcones, isoflavones, provitamin A hydrocarbon carotenoids, non-provitamin A carotenoids, hydroxycarotenoids, glucosinolates, allium organosulphur compounds, phytosterols, monoterpenes, hydroxycinnamates, phenolic acids, stilbenes, choline derivatives, or a combination thereof.
The minimum value will generally be determined depending on the type of nutraceutical composition being considered. For example, a nutraceutical composition of an embodiment of the present invention may include a combination of phytonutrient materials such that the minimum value is about 25. Preferably, the value may be about 40, more preferably about 60.
The nutraceutical composition according to this aspect of the present invention may further include one or more secondary nutraceutical components active nutritionally and/or therapeutically. The secondary nutraceutical component may be selected from one or more of vitamins, minerals, saccharides and/or other carbohydrates, fats, other nutritional supplements, hormones, and pharmaceuticals.
The secondary nutraceutical component, when present, may comprise from approximately 0.05% to 50% by weight, preferably approximately 1% to 40% by weight, more preferably 5% to 25% by weight, based on the total weight of the pharmaceutical composition. The nutraceutical composition according to this aspect of the present invention may further include a pharmaceutically acceptable carrier or excipient.
The nutraceutical composition may be formulated for administration utilising a suitable route. The nutraceutical composition may be formulated for oral, topical, intravenous, intramuscular, intrarectal, transdermal, sublingual, subcutaneous or intranasal administration. An oral or topical route is preferred.
When an oral route is chosen, the nutraceutical composition may be formulated as a food ingredient, food additive, tablet, capsule including soft gelatine capsules, caplet, lozenge, liquid including syrup, oil and suspension, powder, granules, chewing gum or the like.
When a topical route is chosen, the nutraceutical composition may be formulated as a liquid, oil, paste, solution, dispersion, emulsion, lotion, gel, varnish or cream.
In a preferred embodiment, the nutraceutical composition according to this aspect of the present invention may include a source of monounsaturated fatty acids or a derivative thereof. Preferably, the source of the monounsaturated fatty acid is an edible oil. More preferably the edible oil is olive oil or red palm oil, or an extract thereof, or a mixture thereof.
Preferably, the source of monounsaturated fatty acids is present in an amount of from approximately 1 mg to 25 g, preferably 50 mg to 10 g, more preferably 100 mg to 5 g. In a further preferred embodiment of the present invention, the amount of monounsaturated fatty acids present in the nutraceutical composition amounts to a preferred daily intake of the monounsaturated fatty acids.
In another preferred embodiment of this aspect of the present invention, the nutraceutical composition includes an extract from one or more of leafy green vegetables, garlic, onion, leeks, apple, pear, dried fruits or other food sources of the required phytonutrients, or a mixture thereof, with a source of monounsaturated fatty acids. Preferably, the source of the monounsaturated fatty acid is an edible oil. Most preferably, the edible oil is olive oil or red palm oil, an extract thereof, or a mixture thereof.
In addition, the nutraceutical composition may optionally include a nutraceutically acceptable carrier.
Preferably, the extracts of the plant components are present in an amount of approximately 1 % to 99% by weight, preferably approximately 5% to 75% by weight, preferably approximately 10 to 50% by weight, based on the total weight of the composition.
In a further aspect of the present invention, there is provided a cosmetic composition including one or more extracts of one or more plant components, the extracts providing a combination of phytonutrient materials, the type and amount of which are in excess of a minimum value predetermined to provide a therapeutically or prophylactically desirable effect.
Preferably, the cosmetic composition includes an effective amount of phytonutrient materials selected from the group consisting of flavonols, flavones, flavanols, anthocyanidins, flavanones, chalcones, dichalcones, isoflavones, provitamin A hydrocarbon carotenoids, non-provitamin A carotenoids, hydroxycarotenoids, glucosinolates, allium organosulphur compounds, phytosterols, monoterpenes, hydroxycinnamates, phenolic acids, stilbenes, choline derivatives, or a combination thereof.
The minimum value will generally be determined depending on the type of nutraceutical composition being considered. For example, the cosmetic composition according to a preferred aspect of the present invention may include a combination of phytonutrient materials such that the minimum value is about 25. Preferably, the value may be about 40, more preferably about 60.
In a preferred embodiment, the cosmetic composition according to this aspect of the present invention may include a source of monounsaturated fatty acids or a derivative thereof. Preferably, the source of the monounsaturated fatty acid is an edible oil. Most preferably the edible oil is olive oil or red palm oil, or an extract thereof, or a mixture thereof.
Preferably, the source of monounsaturated fatty acids is present in an amount of from approximately 1 mg to 25 g, preferably 50 mg to 10 g, more preferably 100 mg to 5 g. In a further preferred embodiment of the present invention, the amount of monounsaturated fatty acids present in the cosmetic composition amounts to a preferred daily intake of the monounsaturated fatty acids.
In another preferred embodiment of this aspect of the present invention, there is provided a cosmetic composition including an extract from one or more of leafy green vegetables, garlic, onion, leeks, apple, pear, dried fruits or other food sources of the required phytonutrients, or a mixture thereof, with a source of monounsaturated fatty acids. Preferably, the source of the monounsaturated fatty acid is an edible oil. Most preferably, the edible oil is olive oil or red palm oil, an extract thereof, or a mixture thereof.
The cosmetic composition of this aspect of the invention may further include a pharmaceutically acceptable carrier or excipient.
Preferably, the extracts of the plant components are present in an amount of approximately 1 to 99% by weight, preferably approximately 5% to 75% by weight, preferably approximately 10 to 50% by weight, based on the total weight of the composition.
The cosmetic composition may be formulated for administration utilising a suitable route. The cosmetic composition may be formulated for oral, topical, intravenous, intramuscular, intrarectal, transdermal, subcutaneous, sublingual or intranasal administration. An oral or topical route is preferred.
When an oral route is chosen, the nutraceutical composition may be formulated as a food ingredient, food additive, tablet, capsule including soft gelatine capsules, caplet, lozenge, liquid including syrup and oil, suspension, powder, granules, chewing gum or the like.
When a topical route is chosen, the nutraceutical composition may be formulated as a liquid, oil, paste, solution, dispersion, emulsion, lotion, gel, varnish or cream.
The cosmetic composition may also further include one or more cosmetic additives. The cosmetic additives may be selected from the group consisting of water-soluble or liposoluble dyes, fillers, lipophilic or hydrophilic active agents, fragrances, additional carriers or excipients, lubricants, buffers, antibacterials, bulking agents, plasticisers, binding agents, antioxidants and stabilising agents.
Suitable fillers or excipients may be selected from the group consisting of talc, titanium dioxide, starch, cornstarch, modified cornstarch, kaolin, cellulose (microcrystalline or powdered) and mixtures thereof.
Suitable binding agents include polyvinyl pyrrolidine, hydroxypropyl cellulose and hydroxypropyl methyl cellulose.
Suitable solution vehicles include, but are not limited to, ethanol, water, propylene glycol, butylene glycol, acetone, or pharmaceutically acceptable vehicles.
In a further preferred embodiment, the cosmetic composition may further include an active agent selected from the group consisting of hydrating agents, UV screening agents, depigmenting agents, bleaching agents and tensioning agents.
Suitable lotion bases include, but are not limited to, hydrophilic ointment or petrolatum.
Suitable gelling agents include, but are not limited to, xanthan gum, gellan gum, carboxymethylcellulose, polyquaternium-10, methyl cellulose, ethyl cellulose, hydroxyethylcellulose, hydroxypropylcellulose, chitosan, hydroxypropylmethylcellulose, agar-agar, carrageenans, alginates, carob gum, guar gum, gum Arabic, karaya gum, gum tragacanth, ghatti gum, pectins, gelatin, caseinates, hydroxypropyl guar, ammoniated glycyrrhizinate and carbomer. In another aspect of the invention there is provided a modified food composition including a nutraceutical composition, as discussed above. The modified food composition may be characterised by exhibiting a numerical value of phytonutrient quality above a predetermined reference value. The predetermined reference value may equate to a maximum numerical value for an unmodified food composition.
The modified food composition may include any of the following:
• flour based products, including bread, cakes, pastries, pasta etc
• dairy products, including milk, ice-cream, yoghurt, cheese etc
• cereal
• grain based products, including rice based products such as rice cakes, corn based products such as pop corn etc
• confections, including lollies, chocolates and the like
• non-dairy based products, such as soy based products
• products derived at least in part from fruit, including tarts, pies, muesli bars, juices, cordials, tinned fruit, snack foods
• products derived at least in part from vegetables, including soups, juices, snack foods including potato products such as chips, stocks
• nut based products, including snack foods such as nut bars
• pre-packaged meals, including frozen meals
Preferably, the food composition includes an effective amount of phytonutrient materials selected from the group consisting of flavonols, flavones, flavanols, anthocyanidins, flavanones, chalcones, dichalcones, isoflavones, provitamin A hydrocarbon carotenoids, non-provitamin A carotenoids, hydroxycarotenoids, glucosinolates, allium organosulphur compounds, phytosterols, monoterpenes, hydroxycinnamates, phenolic acids, stilbenes, choline derivatives, or a combination thereof.
The minimum value will generally be determined depending on the type of nutraceutical composition being considered. For example, the food composition according to a preferred aspect of the present invention may include a combination of phytonutrient materials such that the minimum value is about 25. Preferably, the value may be about 40, more preferably about 60.
The food composition according to this aspect of the present invention may further include one or more secondary nutraceutical components active nutritionally and/or therapeutically. The secondary nutraceutical component may be selected from one or more of vitamins, minerals, saccharides and/or other carbohydrates, fats, other nutritional supplements, hormones, and pharmaceuticals.
The secondary nutraceutical component, when present, may comprise from approximately 0.05% to 50% by weight, preferably approximately 1% to 40% by weight, more preferably 5% to 25% by weight, based on the total weight of the pharmaceutical composition.
In a preferred embodiment, the composition according to this aspect of the present invention may include a source of monounsaturated fatty acids or a derivative thereof.
Preferably, the source of monounsaturated fatty acids is present in an amount of from approximately 1 mg to 25 g, preferably 50 mg to 10 g, more preferably 100 mg to 5 g. In a further preferred embodiment of the present invention, the amount of monounsaturated fatty acids present in the food composition amounts to a preferred daily intake of the monounsaturated fatty acids. Preferably, the source of monounsaturated fatty acid is an edible oil. More preferably, the edible oil is olive oil, red palm oil or an extract thereof, or a mixture thereof.
In another preferred embodiment of this aspect of the present invention, the composition includes an extract from one or more of leafy green vegetables, garlic, onion, leeks, apple, pear, dried fruits or other food sources of the required phytonutrients, or a mixture thereof, with a source of monounsaturated fatty acids.
Preferably, the extracts of the plant components are present in an amount of approximately 1 to 99% by weight, preferably approximately 5% to 75% by weight, more preferably approximately 10 to 50% by weight, based on the total weight of the composition.
Preferably, the composition is used to prophylactically or therapeutically treat skin ageing, skin health, skin deterioration, skin conditions, cancer, cardiovascular disease, Alzheimer's disease, bone and joint diseases including osteoporosis and arthritis, obstructive airways diseases including asthma, allergic conditions, conditions affecting the gastrointestinal tract, autoimmune diseases, and diabetes..
Preferably, the composition is selected from the group consisting of a nutraceutical composition and a cosmetic composition as described above.
In yet another aspect of the invention there is provided a method of prophylactically or therapeutically treating a disease or degenerative effect which method includes administering to a human a composition including one or more extracts of one or more plant components, the extracts providing a combination of phytonutrient materials, the type and amount of which are in excess of a minimum value predetermined to provide a therapeutically or prophylactically desirable effect.
In another aspect of the present invention there is provided a method of determining the nutritional value of a nutraceutical composition and applying a phytonutrient nutritional score thereto which method includes:
(a) determining a nutritional characteristic(s) of the nutraceutical composition, the nutritional characteristics including phytonutrient content, phytonutrient variety and phytonutrient integrity of the food substance; (b) correlating the nutritional characteristics) with a predetermined value range(s); and
(c) summing the correlated nutritional characteristics to derive a phytonutrient nutritional score indicative of the nutritional value of the nutraceutical composition.
In yet another aspect the present invention provides a method of determining the nutritional value of a food composition and applying a phytonutrient nutritional score thereto. Accordingly, the method includes:
(a) determining a nutritional characteristic(s) of the food substance, the nutritional characteristics including phytonutrient content, phytonutrient variety and phytonutrient integrity of the food substance;
(b) correlating the nutritional characteristic(s) with a predetermined value range(s); and
(c) summing the correlated nutritional characteristics to derive a phytonutrient nutritional score indicative of the nutritional value of the food substance.
The food composition may be of any suitable type as described above. The food substance may include a dietary supplement. The food substance is preferably a flour- based substance, a substance containing and/or consisting of fruit and/or vegetables, a rice-based substance or a dairy-based substance.
The phytonutrient content, phytonutrient variety and phytonutrient integrity may be determined as described above. Preferably, the predetermined value ranges are the Reference Intakes described above. More preferably, the predetermined value ranges are determined at regular intervals based on the information available regarding optimal phytonutrient intake at the time.
The phytonutrient nutritional score may be determined as described above. Preferably, phytonutrient nutritional scores are given in the range of 0 to 100. Preferably, the predetermined value ranges may be compiled in order to create an index of the predetermined value ranges.
Similarly, the phytonutrient nutritional scores which have been determined may be independently compiled in order to create an index of the phytonutrient nutritional scores.
In a further aspect the invention provides a method of controlling the nutritional value of a nutraceutical composition and/or a cosmetic composition and/or a food composition consumed by an individual. Accordingly, the method includes:
(a) determining the phytonutrient nutritional score of a food substance using the abovementioned method of determining the nutritional value of a food substance; and
(b) modifying the nutritional value of a food substance by incorporating an additive into the food substance.
Preferably, the method is used to increase the phytonutrient nutritional score of the food substance.
In yet another aspect the invention provides a computer useable medium for determining the nutritional value of nutraceutical composition and/or a cosmetic composition and/or a food composition. Accordingly, such medium includes:
(a) means for determining nutritional components of the food substance, the nutritional components including phytonutrient content, phytonutrient variety and phytonutrient integrity of the food substance;
(b) means for correlating the nutritional components to predetermined value ranges;
(c) means for summing the correlated nutritional components to derive a phytonutrient nutritional score indicative of the nutritional value of the food substance; and
(d) means for displaying the phytonutrient nutritional score.
The computer useable medium may be stored in any suitable manner known per se in the prior art. For example the medium may be selected from a compact disk, digital video disk, hard drive or floppy disk.
Preferably, the computer useable medium is arranged to provide, as an output, a phytonutrient nutritional score and/or a list of any phytonutrient nutritional scores determined by the method described above so as to form an index of phytonutrient nutritional scores.
The present invention will now be more fully described with reference to the accompanying example. It should be understood, however, that the description following is illustrative only and should not be taken in any way as a restriction on the generality of the invention described above.
EXAMPLE 1 - Calculating Reference Intakes
The following Reference Intakes were calculated based on the data published in the cited references. Generally, data from reports of daily intakes of sub-groups of phytonutrients in populations or sub-populations with longevity or reduced risk of chronic disease were compared and a representative daily intake was calculated for each sub-group of phytonutrients. The Reference Intake, measured in mg/100kcal was calculated from the representative daily intake based on a 2000 kcal per day diet. Table 5 - Reference Intakes
Phytonutrient Average Intakes/Reference Intakes Reference
Flavonoids
Flavonols Average Intakes
Denmark: 15-30 mg/d Dragsted et al. (1997)
Finland: 4 mg/d Knekt et al. (2000)
Japan: 16 mg/d (women) Arai et al. (2000)
USA: 20-22 mg/d Sampson et al. (2002)
USA: 20 mg/d Rimm et al. (1996)
(middle-aged to older men) Reference Intakes (2000 kcal/d)
20 mg/d (~ 1 mg/ 100 kcal)
Flavanols Estimated Daily Intakes
USA: 50-70 mg/d Gu et al. (2004)
Netherlands: 72 mg/d Arts et al. (2001) Reference Intakes (2000 kcal/d)
Proanthocyanins (food extract) Bagchi et al. (2003)
160 mg/d (~8 mg/100 kcal)
Anthocyanidins Estimated Daily Intakes
Acceptable Daily intake (ADI) Clifford (2000a) 150-175 mg/d
Reference Intake (2000 kcal/d)
150-175 mg/d (~8 mg/100 kcal) Clifford (2000a)
Carotenoids
Provitamin A Estimated Daily Intakes hydrocarbon
USA: 2.2 mg/d Chung-Ahuja et al. (1993)
USA: 3.8 mg/d Forman et al. (1993)
Australia: 4.4 mg/d Wahlqvist et al. (1994)
Australia: 7.0 mg/d (Anglo-Celts) Wattanapenpaiboon (1995)
Reference Intakes (2000 kcal/d)
1-2 mg/d Scientific Committee on Food ~ 100 μg/100 kcal under the European Commission (Sep 2000) The Reference Intakes calculated above, in addition to other Reference Intakes, are used in the following examples.
EXAMPLE 2 - Apple (fresh produce)
The types and amounts of sub-groups of phytonutrients present in 10Og of raw apple, including the skin of the apple, were determined and calculated. The phytonutrient density (mg/100kcal) of the apple was then calculated based on the amount of each identified sub-group of phytonutrients contained in the 10Og, given that 100g of raw apple contained 52 kcal. The percentage of the Rl was then calculated for each phytonutrient sub-group.
The results of example 2 are summarised in Tables 6 and 7.
Table 6 - Phytonutrient analysis of 100g of raw apple, including the skin of the apple
Figure imgf000026_0001
Table 7 - Score for 10Og of raw apple, including the skin of the apple
Figure imgf000027_0001
The component 1 to 3 scores were proportionately assigned based on the percentage Rl of the sub-group having the highest percentage Rl. In this example, the score for the carotenoid group was calculated based on the percentage Rl of the hydroxy carotene sub-group alone, 19 being 77% of the possible total of 25.
The variety score (component 4) was determined by summing the number of phytonutrient sub-groups having a value of greater than 5% of the Rl for that phytonutrient sub-group.
As the apple is fresh produce, the integrity score (component 5) is the maximum score available.
EXAMPLE 3 - Salad vegetables
The calculations and determinations described in example 2 were conducted on 100g of salad vegetables having the following approximate portions:
Lettuce 4O g
Celery 2O g
Asparagus 15 g
Avocado 10 g
Cucumber 15 g The results of example 3 are summarised in Tables 8 and 9.
Table 8 - Phytonutrient analysis of 100g of salad vegetables
Figure imgf000028_0001
Table 9 - Score for 100g of salad vegetables
Figure imgf000028_0002
As the percentage Rl for the flavanol sub-group was less than that of the flavonol and flavone sub-groups, it was disregarded when assigning the score for the flavonoid group.
Of the flavonoid sub-groups identified in the salad vegetables, the percentage Rl of the flavanols, 4%, indicated that the flavanols did not contribute substantially to meeting the flavonoid group (component 1) requirement. Accordingly, the flavanol sub-group was not counted in the determination of the variety score.
Again, the integrity score assigned to the salad vegetables was the maximum score available as the salad vegetables had not undergone any processing steps which diminished the phytonutrient integrity of the salad vegetables.
EXAMPLE 4 - Ready-to-Eat soup (70% vegetables)
The calculations and determinations described in example 2 were conducted on 10Og of ready-to-eat soup containing 70% vegetables, the vegetables having the following approximate proportions:
Carrots 15 g
Potatoes 40 g
Pumpkins 10 g
Onions 3 g
Capsicums 2 g
The results of example 4 are summarised in Tables 10 and 11.
Table 10 - Phytonutrient analysis of 100g of ready-to-eat soup
Figure imgf000029_0001
Table 11 - Score for 10Og of ready-to-eat soup
Figure imgf000030_0001
As the percentage Rl of the flavonol sub-group was higher than that of the flavone sub¬ group, it was used as the basis for assigning the flavonoid group score.
As each sub-group had greater than 5% Rl, all four sub-groups were counted toward the variety score.
Again, the integrity score assigned to the ready-to-eat soup was the maximum score available as no processing steps which diminished the phytonutrient integrity of the vegetables had been undergone by the food.
EXAMPLE 5 - Flavoured (dairy and soy) drink
The calculations and determinations described in example 2 were conducted on 10Og of flavoured (dairy and soy) drink having the following approximate proportions of ingredients:
Non-fat milk 98 g Soy isoflavones 15.7 mg
Nutrifood® Wild berries 1.3 g (see www.nutrifood.com for more details)
The results of example 5 are summarised in Tables 12 and 13. Table 12 - Phytonutrient analysis of 100g of flavoured (dairy and soy) drink
Figure imgf000031_0001
* Mazza G, Miniati E. Anthocyanins in Fruits, Vegetables, and Grains. CRC Press, Florida, USA, 993.
Table 13 - Score for 100g of flavoured (dairy and soy) drink
Figure imgf000031_0002
The integrity score assigned to the milk drink was the minimum score available due to the high number of processing steps the product was subjected to which diminished the phytonutrient integrity of the drink.
It will be understood that the invention disclosed and defined in this specification extends to all alternative combinations of two or more of the individual features mentioned or evident from the text or drawings. All of these different combinations constitute various alternative aspects of the invention. Reference to any prior art in the specification is not, and should not be taken as, an acknowledgement or any form of suggestion that this prior art forms part of the common general knowledge in Australia or any other jurisdiction or that this prior art could be reasonably be expected to be ascertained, understood and regarded as relevant by a person skilled in the art.

Claims

1. A nutraceutical composition including one or more extracts of one or more plant components, the one or more extracts providing a combination of phytonutrient materials, the type and amount of which are in excess of a minimum value predetermined to provide a therapeutically or prophylactically desirable effect.
2. A nutraceutical composition according to claim 1 including an effective amount of phytonutrient materials selected from the group consisting of flavonols, flavones, anthocyanidins, flavanones, chalcones, dichalcones, isoflavones, provitamin A hydrocarbon carotenoids, non-provitamin A carotenoids, hydroxycarotenoids, glucosinolates, allium organosulphur compounds, phytosterols, monoterpenes, hydroxycinnamates, phenolic acids, stilbenes, choline derivatives, or a combination thereof.
3. A nutraceutical composition according to claim 1 , wherein the minimum value is about 25.
4. A nutraceutical composition according to claim 1 , wherein the composition further includes one or more secondary nutraceutical components active nutritionally and/or therapeutically.
5. A nutraceutical composition according to claim 4, wherein the secondary nutraceutical component is selected from one or more of vitamins, minerals, saccharides and/or other carbohydrates, fats, other nutritional supplements, hormones and pharmaceuticals.
6. A nutraceutical composition according to claim 4, wherein the secondary nutraceutical component is present in an amount from approximately 0.05% to 50% by weight, based on the total weight of the pharmaceutical composition.
7. A nutraceutical composition according to claim 6, wherein the secondary nutraceutical component is present in an amount of from approximately 1% to 40%, based on the total weight of the pharmaceutical composition.
8. A nutraceutical composition according to claim 1 , wherein the nutraceutical composition further includes a pharmaceutically acceptable carrier or excipient.
9. A nutraceutical composition according to any one of claims 1 , wherein the composition includes a source of monounsaturated fatty acids or a derivative thereof.
10. A nutraceutical composition according to claim 9 wherein the edible oil is olive oil or red palm oil, or an extract thereof, or a mixture thereof.
11. A nutraceutical composition according to claim 9, wherein the source of monounsaturated fatty acids is present in an amount of from approximately 1 mg to 25 g.
12. A nutraceutical composition according to claim 11 , wherein the source of monounsaturated fatty acids is present in an amount of from approximately 50 mg to 10 g.
13. A nutraceutical composition according to claim 1 including an extract from one or more of leafy green vegetables, garlic, onion, leeks, apple, pear, dried fruits, or other food sources of the required phytonutrients, or a mixture thereof, with a source of monounsaturated fatty acids.
14. A nutraceutical composition according to claim 13, wherein the source of monounsaturated fatty acid is olive oil or red palm oil, an extract thereof or a mixture thereof.
15. A nutraceutical composition according to claim 13, further including a nutraceutically acceptable carrier.
16. A nutraceutical composition according to claim 13, wherein the extract is present in an amount of from approximately 1% to 99% by weight, based on the total weight of the composition.
17. A nutraceutical composition according to claim 16, wherein the extract is present in an amount of from approximately 5% to 75% by weight, based on the total weight of the composition.
18. A nutraceutical composition according to claim 17, wherein the extract is present in an amount of from approximately 10% to 50% by weight, based on the total weight of the composition.
19. A cosmetic composition including one or more extracts of one or more plant components, the extracts providing a combination of phytonutrient materials, the type and amount of which are in excess of a minimum value predetermined to provide a therapeutically or prophylactically desirable effect.
20. A cosmetic composition according to claim 19 including an effective amount of phytonutrient materials selected from the group consisting of flavonols, flavones, anthocyanidins, flavanones, chalcones, dichalcones, isoflavones, provitamin A hydrocarbon carotenoids, non-provitamin A carotenoids, hydroxycarotenoids, glucosinolates, allium oganosulphur compounds, phytosterols, monoterpenes, hydroxycinnamates, phenolic acids, stilbenes, choline derivatives, or a combination thereof.
21. A cosmetic composition according to claim 19, wherein the minimum value is about 25.
22. A cosmetic composition according to claim 19, wherein the composition includes a source of monounsaturated fatty acids or a derivative thereof.
23. A cosmetic composition according to claim 22, wherein the source of monounsaturated fatty acids is olive oil or red palm oil, or an extract thereof, or a mixture thereof.
24. A cosmetic composition according to claim 23, wherein the source of monounsaturated fatty acids is present in an amount of from approximately 1 mg to 25 g.
25. A cosmetic composition according to claim 19, further including a pharmaceutically acceptable carrier or excipient.
26. A cosmetic composition according to claim 19 including an extract from one or more of leafy green vegetables, garlic, onion, leeks, apple, pear, dried fruits, or other food sources of the required phytonutrients, or a mixture thereof, with a source of monounsaturated fatty acids.
27. A cosmetic composition according to claim 23, wherein the source of monounsaturated fatty acids is olive oil or red palm oil, an extract thereof or a mixture thereof.
28. A cosmetic composition according to claim 26, wherein the extract is present in an amount of from approximately 1 % to 99% by weight, based on the total weight of the composition.
29. A cosmetic composition according to claim 24, wherein the extract is present in an amount of from approximately 5% to 75% by weight, based on the total weight of the composition.
30. A cosmetic composition according to claim 19, further including one or more cosmetic additives.
31. A cosmetic composition according to claim 30, wherein the cosmetic additives may be selected from one or more of water-soluble or liposoluble dyes, fillers, lipophilic or hydrophilic active agents, fragrances, additional carriers or excipients, lubricants, buffers, antibacterials, bulking agents, gelling agents, plasticisers, binding agents, antioxidants and stabilising agents.
32. A cosmetic composition according to claim 19, further including an active agent.
33. A cosmetic composition according to claim 32, wherein the active agent is selected from one or more of the group consisting of hydrating agents, UV screening agents, depigmenting agents, bleaching agents and tensioning agents.
34. A modified food composition including a nutraceutical composition including one or more extracts of one or more plant components, the one or more extracts providing a combination of phytonutrient materials, the type and amount of which are in excess of a minimum value predetermined to provide a therapeutically or prophylactically desirable effect.
35. A modified food composition according to claim 34 including an effective amount of phytonutrient materials selected from the group consisting of flavonols, flavones, anthocyanidins, flavanones, chalcones, dichalcones, isoflavones, provitamin A hydrocarbon carotenoids, non-provitamin A carotenoids, hydroxycarotenoids, glucosinolates, allium organosulphur compounds, phytosterols, monoterpenes, hydroxycinnamates, phenolic acids, stilbenes, choline derivatives, or a combination thereof.
36. A modified food composition according to claim 34, wherein the minimum value is about 25.
37. A modified food composition according to claim 34, wherein the composition further includes one or more secondary nutraceutical components active nutritionally and/or therapeutically.
38. A modified food composition according to claim 37, wherein the secondary nutraceutical component is selected from one or more of vitamins, minerals, saccharides and/or other carbohydrates, fats, other nutritional supplements, hormones and pharmaceuticals.
39. A modified food composition according to claim 38, wherein the secondary nutraceutical component is present in an amount from approximately 0.05% to
50% by weight, based on the total weight of the pharmaceutical composition.
40. A modified food composition according to claim 34, wherein the composition includes a source of monounsaturated fatty acids or a derivative thereof.
41. A modified food composition according to claim 40, wherein the source of monounsaturated fatty acids is present in an amount of from approximately 1 mg to 25 g.
42. A modified food composition according to claim 34 including an extract from one or more of leafy green vegetables, garlic, onion, leeks, apple, pear, dried fruits, or other food sources of the required phytonutrients, or a mixture thereof, with a source of monounsaturated fatty acids.
43. A modified food composition according to claim 42, wherein the extract is present in an amount of from approximately 1% to 99% by weight, based on the total weight of the composition.
44. A method of prophylacticaliy or therapeutically treating a disease or degenerative effect which method includes administering to a human a composition including one or more extracts providing a combination of phytonutrient materials, the type and amount of which are in excess of a minimum value predetermined to provide a therapeutically or prophylacticaliy desirable effect.
45. A method according to claim 44 including an effective amount of phytonutrient materials selected from the group consisting of flavonols, flavones, anthocyanidins, flavanones, chalcones, dichalcones, isoflavones, provitamin A hydrocarbon carotenoids, non-provitamin A carotenoids, hydroxycarotenoids, glucosinolates, allium organosulphur compounds, phytosterols, monoterpenes, hydroxycinnamates, phenolic acids, stilbenes, choline derivatives, or a combination thereof.
46. A method according to claim 44, wherein the method is used to prophylacticaliy or therapeutically treat skin ageing, skin health, skin deterioration, skin conditions, cancer, cardiovascular disease, Alzheimer's disease, bone and joint diseases including osteoporosis and arthritis, obstructive airways diseases, including asthma, allergic conditions, conditions affecting the gastrointestinal tract, autoimmune diseases, and diabetes..
47. A method of determining the nutritional value of a nutraceutical composition and applying a phytonutrient nutritional score thereto which method includes:
(a) determining a nutritional characteristic(s) of the nutraceutical composition, the nutritional characteristics including phytonutrient content, phytonutrient variety and phytonutrient integrity of the food substance;
(b) correlating the nutritional characteristic(s) with a predetermined value range(s); and
(c) summing the correlated nutritional characteristics to derive a phytonutrient nutritional score indicative of the nutritional value of the nutraceutical composition.
48. A method of determining the nutritional value of a food composition and applying a phytonutrient nutritional score thereto which method includes:
(a) determining a nutritional characteristic(s) of the food substance, the nutritional characteristics including phytonutrient content, phytonutrient variety and phytonutrient integrity of the food substance;
(b) correlating the nutritional characteristic(s) with a predetermined value range(s); and
(c) summing the correlated nutritional characteristics to derive a phytonutrient nutritional score indicative of the nutritional value of the food substance.
49. A method of controlling the nutritional value of a nutraceutical composition consumed by an individual, which method includes:
(a) determining the phytonutrient nutritional score of a nutraceutical composition using a method according to claim 47; and
(b) modifying the nutritional value of a nutraceutical composition by incorporating an additive into the food substance.
50. A method of controlling the nutritional value of a food composition consumed by an individual, which method includes:
(a) determining the phytonutrient nutritional score of a food substance using a method according to claim 48; and
(b) modifying the nutritional value of a food substance by incorporating an additive into the food substance.
51. A computer useable medium for determining the nutritional value of a nutraceutical composition including:
(a) means for determining nutritional components of the nutraceutical composition, the nutritional components, phytonutrient variety and phytonutrient integrity of nutraceutical composition;
(b) means for correlating the nutritional components to predetermined value ranges;
(c) means for summing the correlated nutritional components to derive a phytonutrient score indicative of the nutritional value of the nutraceutical composition; and
(d) means for displaying the phytonutrient nutritional score.
52. A computer useable medium for determining the nutritional value of a food composition including:
(a) means for determining nutritional components of the food substance, the nutritional components, phytonutrient variety and phytonutrient integrity of the food substance;
(b) means for correlating the nutritional components to predetermined value ranges;
(c) means for summing the correlated nutritional components to derive a phytonutrient score indicative of the nutritional value of the food substance; and
(d) means for displaying the phytonutrient nutritional score.
53. A computer useable medium for determining the nutritional value of a cosmetic composition including:
(a) means for determining nutritional components of the food substance, the nutritional components, phytonutrient variety and phytonutrient integrity of the food substance;
(b) means for correlating the nutritional components to predetermined value ranges;
(c) means for summing the correlated nutritional components to derive a phytonutrient score indicative of the nutritional value of the food substance; and
(d) means for displaying the phytonutrient nutritional score.
54. A method according to claim 51 , wherein the computer usable medium is arranged to provide, as an output, a phytonutrient nutritional score and/or a list of any phytonutrient nutritional scores.
55. A method according to claim 52, wherein the computer usable medium is arranged to provide, as an output, a phytonutrient nutritional score and/or a list of any phytonutrient nutritional scores.
56. A method according to claim 53, wherein the computer usable medium is arranged to provide, as an output, a phytonutrient nutritional score and/or a list of any phytonutrient nutritional scores.
PCT/AU2005/001741 2004-11-16 2005-11-16 Improved nutraceutical composition WO2006053379A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2005306575A AU2005306575A1 (en) 2004-11-16 2005-11-16 Improved nutraceutical composition

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AU2004906558A AU2004906558A0 (en) 2004-11-16 Nutraceutical composition (3)
AU2004906558 2004-11-16
AU2005900508 2005-02-04
AU2005900508A AU2005900508A0 (en) 2005-02-04 Improved nutraceutical composition

Publications (1)

Publication Number Publication Date
WO2006053379A1 true WO2006053379A1 (en) 2006-05-26

Family

ID=36406764

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/AU2005/001741 WO2006053379A1 (en) 2004-11-16 2005-11-16 Improved nutraceutical composition

Country Status (1)

Country Link
WO (1) WO2006053379A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008080037A2 (en) * 2006-12-21 2008-07-03 Isp Investments Inc. Carotenoids of enhanced bioavailability
US9937220B2 (en) 2009-03-24 2018-04-10 Universiti Putra Malaysia Anti-diabetic nutraceutical composition from palm leaf extract

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0954984A1 (en) * 1998-05-04 1999-11-10 Källna Specialprodukter AB Dietary fibre composition
EP1026164A1 (en) * 1999-02-02 2000-08-09 ADM Cocoa B.V. Process for extracting polyphenolic antioxidants from purine-containing plants
WO2000064282A1 (en) * 1999-04-27 2000-11-02 Diomede Antonio Tortora Nutraceuticals and ingredients for functional foods
WO2003017784A1 (en) * 2001-08-30 2003-03-06 Council Of Scientific And Industrial Research Herbal nutraceutical formulation for females/expectant mothers and its process of preparation
WO2003055324A1 (en) * 2001-12-21 2003-07-10 Raisio Benecol Oy Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis
US20030185911A1 (en) * 2002-03-25 2003-10-02 Qazi Gulam Nabi Herbal nutraceuticals and a process for preparing the same
WO2004023889A2 (en) * 2002-09-12 2004-03-25 Armadillo Pharmaceuticals Full range nutritional supplements from plant materials and methods for their manufacture
US20040071752A1 (en) * 1999-11-06 2004-04-15 Janmarie Hornack Dietary supplement containing alkaline electrolyte buffers

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0954984A1 (en) * 1998-05-04 1999-11-10 Källna Specialprodukter AB Dietary fibre composition
EP1026164A1 (en) * 1999-02-02 2000-08-09 ADM Cocoa B.V. Process for extracting polyphenolic antioxidants from purine-containing plants
WO2000064282A1 (en) * 1999-04-27 2000-11-02 Diomede Antonio Tortora Nutraceuticals and ingredients for functional foods
US20040071752A1 (en) * 1999-11-06 2004-04-15 Janmarie Hornack Dietary supplement containing alkaline electrolyte buffers
WO2003017784A1 (en) * 2001-08-30 2003-03-06 Council Of Scientific And Industrial Research Herbal nutraceutical formulation for females/expectant mothers and its process of preparation
WO2003055324A1 (en) * 2001-12-21 2003-07-10 Raisio Benecol Oy Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis
US20030185911A1 (en) * 2002-03-25 2003-10-02 Qazi Gulam Nabi Herbal nutraceuticals and a process for preparing the same
WO2004023889A2 (en) * 2002-09-12 2004-03-25 Armadillo Pharmaceuticals Full range nutritional supplements from plant materials and methods for their manufacture

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BAMBA T. ET AL: "A new prebiotic from germinated barley for nutraceutical treatment of ulcerative colitis", JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 17, 2002, pages 818 - 824 *
JARIWALLA R.J.: "Rice-bran products: phytonutrients with potential applications in preventive and clinical medicine", DRUGS EXPTL. CLIN. RES, vol. XXVII, no. 1, 2001, pages 17 - 26 *
OH S.-H. ET AL: "Germinated Brown Rice Extract Shows a Nutraceutical Effect in the Recovery of Chronic Alcohol-Related Symptoms", JOURNAL OF MEDICINAL FOOD, vol. 6, no. 2, 2003, pages 115 - 121 *
WATTANAPENPAIBOON N. ET AL: "Phytonutrient deficiency: the place of palm fruit", ASIA PACIFIC J CLIN NUTR, vol. 12, no. 3, 2003, pages 363 - 368 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008080037A2 (en) * 2006-12-21 2008-07-03 Isp Investments Inc. Carotenoids of enhanced bioavailability
WO2008080037A3 (en) * 2006-12-21 2008-11-27 Isp Investments Inc Carotenoids of enhanced bioavailability
US8613946B2 (en) 2006-12-21 2013-12-24 Isp Investment Inc. Carotenoids of enhanced bioavailability
US9937220B2 (en) 2009-03-24 2018-04-10 Universiti Putra Malaysia Anti-diabetic nutraceutical composition from palm leaf extract

Similar Documents

Publication Publication Date Title
Drabińska et al. Broccoli by-products improve the nutraceutical potential of gluten-free mini sponge cakes
Gupta et al. Functional food with some health benefits, so called superfood: A review
Sidhu et al. Bioactive compounds in banana fruits and their health benefits
Yahia et al. The contribution of fruit and vegetable consumption to human health
Singh et al. Bioactive compounds in banana and their associated health benefits–A review
Swami et al. Jackfruit and its many functional components as related to human health: a review
Hui et al. Handbook of vegetable preservation and processing
Dixit et al. Functional foods: Exploring the health benefits of bioactive compounds from plant and animal sources
Liu Potential synergy of phytochemicals in cancer prevention: mechanism of action
Das et al. Black rice: A comprehensive review on its bioactive compounds, potential health benefits and food applications
Denny et al. Plant foods and health: focus on plant bioactives
Pérez-Chabela et al. Agroindustrial coproducts as sources of novel functional ingredients
Sawicka et al. Nutraceuticals in food and pharmacy. A Review
Fardet New concepts and paradigms for the protective effects of plant-based food components in relation to food complexity
Shajan et al. Comprehensive comparative insights on physico-chemical characteristics, bioactive components, and therapeutic potential of pumpkin fruit
Sharma et al. Bioavailability of nutrients and safety measurements
Anandhi et al. Extraction and food enrichment applications of black carrot phytocompounds: A review
Alu'datt et al. Date palm (Phoenix dactylifera) bioactive constituents and their applications as natural multifunctional ingredients in health‐promoting foods and nutraceuticals: A comprehensive review
Kalia et al. Nutritional enhancement of vegetable crops (with major emphasis on Broccoli: a new cole crop in India)
Turturică et al. Carrot–Application in food industry and health benefits–review
Rajput et al. Pistachio
Lindsay The nutritional enhancement of plant foods in Europe ‘NEODIET’
Singh Bioactive nutrients in vegetables for human nutrition and health
Wahlqvist et al. Phytonutrients as Bioactive Food Components
WO2006053379A1 (en) Improved nutraceutical composition

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2005306575

Country of ref document: AU

Ref document number: 555199

Country of ref document: NZ

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2005306575

Country of ref document: AU

Date of ref document: 20051116

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2005306575

Country of ref document: AU

122 Ep: pct application non-entry in european phase

Ref document number: 05803023

Country of ref document: EP

Kind code of ref document: A1